Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$3.1B
239M shares
52-week range
$7.11 – $17.09
55% from low
Sector
SERVICES-NURSING & PERSONAL CARE FACILITIES
Exchange
NYSE
CS
Brookdale Senior Living Inc operates senior living communities throughout the United States. The company has three reportable segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRs). The majority of the revenue is generated from the Assisted Living and Memory Care segment, which offers housing and assistance with activities of daily living to its customers. The company generates revenue in the form of Resident Fees, which it receives in exchange for the services provided, and in the form of management fees from certain communities under contract in exchange for the management services provided.
www.brookdale.comNo one on the platform currently holds BKD.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 7,663,564 | $104.8M |
No one on the platform has traded BKD yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
Wall St is expecting -0.03 EPS for $BKD Q3 [Reporting 11/09 AMC] http://www.estimize.com/intro/bkd?chart=historical&metric_name=eps&utm_con
View on StockTwits ↗$BKD This will drop tomorrow like All of the senior living names have after earnings but will recover by end of day.
View on StockTwits ↗$BKD Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.10 up 155.56% YoY • Reported revenue of $718.58M down -11.61% YoY
View on StockTwits ↗$BKD LFG https://www.prnewswire.com/news-releases/brookdale-announces-acquisition-of-17-leased-communities-and-refinances-all-mortgage-debt-maturities-until-2028-302843997.html
View on StockTwits ↗$BKD Has been steadily improving from post-pandemic lows. Because many operating costs are fixed, higher occupancy can meaningfully expand margins and cash floww…
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $3.0B | -7.4% | $-0.13 | $-0.13–$-0.13 | — | 2 |
| 2027 | $3.1B | +3.4% | $0.14 | $0.14–$0.14 | 87.6× | 3 |
| 2028 | $3.2B | +5.4% | $0.47 | $0.38–$0.56 | 26.7× | 2 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 2 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-10 | $-0.06 | $0.10 | +280.2% |
| 2026-05-06 | $0.03 | $-0.03 | -200.0% |
| 2026-02-18 | $-0.16 | $-0.17 | -6.3% |
| 2025-11-06 | $-0.16 | $-0.20 | -25.0% |
| 2025-08-06 | $-0.14 | $-0.18 | -28.6% |
| 2025-05-06 | $-0.11 | $-0.11 | +0.0% |
| 2025-02-18 | $-0.16 | $-0.37 | -131.3% |
| 2024-11-07 | $-0.17 | $-0.22 | -29.4% |
| +24.75% |
| $2.5B |
| — |
| COGTCogent Biosciences, Inc. | $37.31 | -4.28% | $6.4B | — |
| DNLIDenali Therapeutics Inc. | $24.82 | -1.78% | $3.9B | — |
Source: Financial Modeling Prep · peers by sector/industry